Goswami C[au] - Search Results

Year	Number of Results
1996	1
2002	1
2004	4
2005	1
2006	2
2007	6
2008	3
2010	7
2011	7
2012	10
2013	17
2014	21
2015	18
2016	14
2017	12
2018	15
2019	10
2020	18
2021	17
2022	18
2023	5

1

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, Dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J; REGARD Trial Investigators. Fuchs CS, et al. Among authors: goswami c. Lancet. 2014 Jan 4;383(9911):31-39. doi: 10.1016/S0140-6736(13)61719-5. Epub 2013 Oct 3. Lancet. 2014. PMID: 24094768 Clinical Trial.

2

Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways.

Gökmen-Polar Y, Neelamraju Y, Goswami CP, Gu Y, Gu X, Nallamothu G, Vieth E, Janga SC, Ryan M, Badve SS. Gökmen-Polar Y, et al. Among authors: goswami cp. EMBO Rep. 2019 Feb;20(2):e46078. doi: 10.15252/embr.201846078. Epub 2019 Jan 21. EMBO Rep. 2019. PMID: 30665944 Free PMC article.

3

TRPV4-mediated channelopathies.

Verma P, Kumar A, Goswami C. Verma P, et al. Among authors: goswami c. Channels (Austin). 2010 Jul-Aug;4(4):319-28. doi: 10.4161/chan.4.4.12905. Epub 2010 Jul 6. Channels (Austin). 2010. PMID: 20676052 Review.

4

Rare variants: data types and analysis strategies.

Goswami C, Chattopadhyay A, Chuang EY. Goswami C, et al. Ann Transl Med. 2021 Jun;9(12):961. doi: 10.21037/atm-21-1635. Ann Transl Med. 2021. PMID: 34277761 Free PMC article. No abstract available.

5

TRPM8 channel augments T-cell activation and proliferation.

Acharya TK, Tiwari A, Majhi RK, Goswami C. Acharya TK, et al. Among authors: goswami c. Cell Biol Int. 2021 Jan;45(1):198-210. doi: 10.1002/cbin.11483. Epub 2020 Oct 30. Cell Biol Int. 2021. PMID: 33090595

6

A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review.

Talukder A, Kalita C, Neog N, Goswami C, Sarma MK, Hazarika I. Talukder A, et al. Among authors: goswami c. Z Naturforsch C J Biosci. 2022 Mar 2;77(7-8):351-362. doi: 10.1515/znc-2021-0301. Print 2022 Jul 26. Z Naturforsch C J Biosci. 2022. PMID: 35245422 Free article. Review.

7

Both heat-sensitive TRPV4 and cold-sensitive TRPM8 ion channels regulate microglial activity.

Chakraborty R, Goswami C. Chakraborty R, et al. Among authors: goswami c. Biochem Biophys Res Commun. 2022 Jun 30;611:132-139. doi: 10.1016/j.bbrc.2022.04.032. Epub 2022 Apr 14. Biochem Biophys Res Commun. 2022. PMID: 35489198

8

Cytochrome C interacts with the pathogenic mutational hotspot region of TRPV4 and forms complexes that differ in mutation and metal ion-sensitive manner.

Das R, Kumar A, Dalai R, Goswami C. Das R, et al. Among authors: goswami c. Biochem Biophys Res Commun. 2022 Jun 30;611:172-178. doi: 10.1016/j.bbrc.2022.04.066. Epub 2022 Apr 17. Biochem Biophys Res Commun. 2022. PMID: 35490656

9

Hydrogel-Mediated Release of TRPV1 Modulators to Fine Tune Osteoclastogenesis.

Chakraborty R, Acharya TK, Tiwari N, Majhi RK, Kumar S, Goswami L, Goswami C. Chakraborty R, et al. Among authors: goswami c. ACS Omega. 2022 Mar 9;7(11):9537-9550. doi: 10.1021/acsomega.1c06915. eCollection 2022 Mar 22. ACS Omega. 2022. PMID: 35350319 Free PMC article.

10

Role of TRPV4 in skeletal function and its mutant-mediated skeletal disorders.

Das R, Goswami C. Das R, et al. Among authors: goswami c. Curr Top Membr. 2022;89:221-246. doi: 10.1016/bs.ctm.2022.07.004. Epub 2022 Sep 2. Curr Top Membr. 2022. PMID: 36210150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results